Additional file 3: of The neoepitope landscape of breast cancer: implications for immunotherapy

Karen Anderson (Contributor)
Pooja Narang (Contributor)
Meixuan Chen (Contributor)
Amit A. Sharma (Contributor)
Melissa Wilson (Contributor)

Dataset

Description

Figure S1. Frequently mutated genes in TCGA breast cancer data. Here we show the mo for: (A) ER/PR(+)HER-2(â ) breast cancers, (B) HER-2(+) breast cancers, and (C) TNBC. The % Mutant indicates the percentage of samples with a mutation in the annotated particular gene (PDF 179 kb)

Date made available	Mar 4 2019
Publisher	figshare Academic Research System

DOI
10.6084/m9.figshare.7802207.v1

Access Dataset

https://doi.org/10.6084%2Fm9.figshare.7802207.v1

1 Article

The neoepitope landscape of breast cancer: Implications for immunotherapy
Narang, P., Chen, M., Sharma, A. A., Anderson, K. & Wilson, M. A., Mar 4 2019, In: BMC Cancer. 19, 1, 200.
Research output: Contribution to journal › Article › peer-review

Open Access
50 Scopus citations

Additional file 3: of The neoepitope landscape of breast cancer: implications for immunotherapy

Description

DOI

Access Dataset

Research output

The neoepitope landscape of breast cancer: Implications for immunotherapy

Cite this